Orexigen Therapeutics Inc(OREX)
0.22
Change: 0 (0)
As of Wed 04/03/2019 09:40 PM% Of Value
Growth
Value Per Share
:
:
:
-1.41
37.82
-5.7200 (as of 03/04/2018)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 0.24 | Dividend | 15 |
| Close Price | 0.22 | DivYield | 0 % |
| High | 0.3198 | Growth | 0.0 |
| Low | 0.22 | Growth% | 37.82 |
| P/e | -2.415 | Volume | 3.7 M |
| P/b | -5.4 | Market Capital | 3.2 M |
| Highest High | 5.43 | Lowest Low | 1.61 |
| 50 Days Moving Average | 3.34 (as of 03/04/2019) | 50 Days Moving Average Percentage | -35.802 (as of 03/04/2019 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 | Year2 | Year3 | Year4 | Current Year / 2016 |
| Revenue | 0.0 | 0.0 | 55.5 M | 24.4 M | 33.7 M |
| Cap Spending | 0.0 | 0.0 | -246,000.0 | -538,000.0 | -330,000.0 |
| Operating Expenses | 0.0 | 0.0 | 86.0 M | 84.5 M | 79.6 M |
| Operating Cash Flow | 0.0 | 0.0 | -30.5 M | -60.0 M | -53.9 M |
| Free Cash Flow | 0.0 | 0.0 | 26.5 M | -55.0 M | -110.0 M |
| Free Cash Flow Per Share | 2.248 | -4.195 | -7.55 | ||
| Total liabilities | 0.0 | 0.0 | 83.9 M | 88.1 M | 166.1 M |
| Total cash | 0.0 | 0.0 | 104.4 M | 155.5 M | 182.6 M |
| ROE% | -2.476 | -3.135 | -0.747 | ||
| Outstanding Shares | 0.0 | 0.0 | 12.3 M | 14.5 M | 15.2 M |
| P/E | -18.596 | -2.056 | -2.415 | ||
| P/S | 12.569 | 5.773 | 1.757 | ||
| Revenue USD | 0.0 | 0.0 | 55.5 M | 24.4 M | 33.7 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|